You searched for liver disease | Page 110 of 420

OncoHost Develops Predictive Biomarker for Immune-Related Adverse Events in NSCLC Patients

Posted by Andy Lundin | Oct 31, 2023 | Lung Cancer |

OncoHost developed a novel computational model for predicting significant immune-related adverse events in NSCLC patients.

Diadem formed a strategic collaboration with Quest Diagnostics to improve access to blood tests for evaluating the risk of Alzheimer’s.

Cordance Medical’s device, NeuroAccess, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

Posted by Andy Lundin | Oct 26, 2023 | Cardiovascular |

Mindray introduced new cardiac biomarkers aimed at diversifying its portfolio for cardiovascular disease diagnosis and management.

Posted by Andy Lundin | Oct 26, 2023 | Cancer, Company News |

QIAGEN and Myriad Genetics announced a new master collaboration agreement to develop companion diagnostic tests in the field of cancer.